S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:TXMD

TherapeuticsMD (TXMD) News Today

$4.15
+0.04 (+0.97%)
(As of 05/31/2023 ET)
Compare
Today's Range
$4.03
▼
$4.18
50-Day Range
$3.42
▼
$4.49
52-Week Range
$3.25
▼
$11.69
Volume
7,591 shs
Average Volume
40,431 shs
Market Capitalization
$42.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Get TherapeuticsMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.



TXMD Media Mentions By Week

TXMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TXMD
News Sentiment
▼
1.89

0.79
▲
Average
Medical
News Sentiment

TXMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TXMD Articles
This Week
▼
0

2
▲
TXMD Articles
Average Week

SourceHeadline
seekingalpha.com logoTherapeuticsMD: From Fallen And Forgotten To Cash Cow
seekingalpha.com - May 23 at 9:28 AM
MarketBeat logoStockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)
americanbankingnews.com - May 20 at 5:26 AM
finance.yahoo.com logoTherapeuticsMD Announces First Quarter 2023 Financial Results
finance.yahoo.com - May 15 at 4:19 PM
marketwatch.com logoTherapeuticsMD Inc. stock falls Tuesday, underperforms market
marketwatch.com - May 10 at 8:44 PM
marketwatch.com logoTherapeuticsMD Inc. stock rises Wednesday, still underperforms market
marketwatch.com - May 10 at 8:44 PM
MarketBeat logoTherapeuticsMD (NASDAQ:TXMD) Shares Down 5.4%
americanbankingnews.com - May 7 at 5:32 AM
marketwatch.com logoTherapeuticsMD Inc. stock falls Monday, underperforms market
marketwatch.com - May 3 at 7:08 AM
marketwatch.com logoTherapeuticsMD Inc. stock underperforms Friday when compared to competitors
marketwatch.com - April 30 at 10:17 AM
MarketBeat logo (NYSE:SNY) vs. (NYSE:TXMD) Financial Survey
americanbankingnews.com - April 24 at 3:38 AM
marketwatch.com logoTherapeuticsMD Inc. stock outperforms market on strong trading day
marketwatch.com - April 23 at 7:27 AM
MarketBeat logoTherapeuticsMD (NYSE:TXMD) & Sanofi (NYSE:SNY) Financial Review
americanbankingnews.com - April 16 at 3:09 AM
MarketBeat logoTherapeuticsMD (NYSE:TXMD) versus Sanofi (NYSE:SNY) Head-To-Head Comparison
americanbankingnews.com - April 16 at 2:32 AM
MarketBeat logoReviewing Sanofi (NYSE:SNY) & TherapeuticsMD (NYSE:TXMD)
americanbankingnews.com - April 16 at 2:32 AM
msn.com logoAll You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
msn.com - April 14 at 1:44 PM
MarketBeat logoCantor Fitzgerald Equities Analysts Boost Earnings Estimates for TherapeuticsMD, Inc. (NASDAQ:TXMD)
americanbankingnews.com - April 14 at 6:34 AM
finance.yahoo.com logoTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
finance.yahoo.com - April 7 at 5:01 PM
marketwatch.com logoTherapeuticsMD Inc. stock underperforms Monday when compared to competitors
marketwatch.com - March 13 at 6:29 PM
bizjournals.com logoTheraputicsMD sells products rights for $153 million
bizjournals.com - January 5 at 10:00 AM
finance.yahoo.com logoTherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
finance.yahoo.com - January 3 at 7:13 AM
reuters.com logoTXMD.A - TherapeuticsMD Inc | Stock Price & Latest News | Reuters
reuters.com - December 26 at 8:32 AM
bizjournals.com logoTechnology & Innovation Roundup: Company will cut 212 employees after failed buyout
bizjournals.com - December 19 at 7:47 AM
marketwatch.com logoTherapeuticsMD Inc. stock falls Thursday, underperforms market
marketwatch.com - December 16 at 2:22 PM
marketwatch.com logoTherapeuticsMD Inc. stock rises Wednesday, outperforms market
marketwatch.com - December 15 at 5:42 AM
finance.yahoo.com logoTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
finance.yahoo.com - December 4 at 9:54 PM
finance.yahoo.com logoTherapeuticsMD Announces Third Quarter 2022 Financial Results
finance.yahoo.com - November 15 at 5:31 AM
finance.yahoo.com logoTherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 15 at 5:31 AM
finance.yahoo.com logoTherapeuticsMD, Inc. (TXMD) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - November 13 at 3:56 PM
finance.yahoo.com logoTherapeuticsMD Announces Additional $7 Million Private Placement
finance.yahoo.com - October 31 at 10:34 AM
bizjournals.com logoTherapeuticsMD receives $7M investment after merger plans unravel - South Florida Business Journal - The Business Journals
bizjournals.com - October 3 at 5:24 PM
finance.yahoo.com logoTherapeuticsMD receives $7M investment after merger plans unravel
finance.yahoo.com - October 3 at 5:24 PM
seekingalpha.com logoTherapeuticsMD rannounces $7 million private placement - Seeking Alpha
seekingalpha.com - October 3 at 12:23 PM
marketscreener.com logoTHERAPEUTICSMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
marketscreener.com - October 3 at 7:23 AM
businesswire.com logoTherapeuticsMD Announces $7 Million Private Placement - Business Wire
businesswire.com - October 3 at 7:23 AM
finance.yahoo.com logoTherapeuticsMD Announces $7 Million Private Placement
finance.yahoo.com - October 3 at 7:23 AM
marketwatch.com logoTherapeuticsMD Inc. stock outperforms market despite losses on the day - MarketWatch
marketwatch.com - September 30 at 9:28 PM
thestreet.com logoTherapeuticsMD (TXMD) Stock Surges on Successful Vaginal Atrophy Drug Trial
thestreet.com - September 17 at 6:29 PM
finance.yahoo.com logoPrenatal Vitamin Supplements Market to record USD 230.86 Mn growth -- Driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers - Yahoo Finance
finance.yahoo.com - September 16 at 5:32 AM
marketscreener.com logoTherapeuticsMD Appoints Brian Bernick, Mark Glickman as Interim Co-CEOs - Marketscreener.com
marketscreener.com - September 12 at 4:59 PM
marketwatch.com logoTherapeuticsMD CEO O'Dowd Steps Down After Less Than a Year - MarketWatch
marketwatch.com - September 12 at 9:03 AM
finance.yahoo.com logoTherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers - Yahoo Finance
finance.yahoo.com - September 12 at 9:03 AM
businesswire.com logoTherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers - Business Wire
businesswire.com - September 12 at 6:59 AM
finance.yahoo.com logoTherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
finance.yahoo.com - September 12 at 6:59 AM
benzinga.com logoTherapeuticsMD (NASDAQ:TXMD) – Looking Into TherapeuticsMD's Return On Capital Employed - Benzinga
benzinga.com - September 9 at 5:22 PM
marketscreener.com logoPrescient Therapeutics, MD Anderson Cancer Center to Develop Blood Cancer Binder for OmniCAR; Shares Rise 3% - Marketscreener.com
marketscreener.com - September 7 at 1:29 AM
fool.com logoTherapeuticsMD, Inc. (NASDAQ: TXMD)
fool.com - September 5 at 12:42 AM
reuters.com logoTXMD.P - TherapeuticsMD Inc | Stock Price & Latest News | Reuters
reuters.com - September 5 at 12:42 AM
seekingalpha.com logoTherapeuticsMD Stock: Looking To Annovera To Save The Day - Seeking Alpha
seekingalpha.com - August 17 at 1:39 PM
greenwichtime.com logoTherapeuticsMD: Q2 Earnings Snapshot - Greenwich Time
greenwichtime.com - August 16 at 8:44 AM
seekingalpha.com logoHot Stocks: VRDN surges 60% on clinical data; TXMD, SNDL rise on earnings; U falls - Seeking Alpha
seekingalpha.com - August 15 at 6:59 PM
seekingalpha.com logoTherapeutics MD GAAP EPS of $12.39, revenue of $28.6M (NASDAQ:TXMD) - Seeking Alpha
seekingalpha.com - August 15 at 6:59 PM
Get TherapeuticsMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TXMD) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -